• Case-Based Roundtable
  • General Dermatology
  • Eczema
  • Chronic Hand Eczema
  • Alopecia
  • Aesthetics
  • Vitiligo
  • COVID-19
  • Actinic Keratosis
  • Precision Medicine and Biologics
  • Rare Disease
  • Wound Care
  • Rosacea
  • Psoriasis
  • Psoriatic Arthritis
  • Atopic Dermatitis
  • Melasma
  • NP and PA
  • Skin Cancer
  • Hidradenitis Suppurativa
  • Drug Watch
  • Pigmentary Disorders
  • Acne
  • Pediatric Dermatology
  • Practice Management
  • Prurigo Nodularis
  • Buy-and-Bill

News

Article

Daily Derm Times: February 17, 2025

Key Takeaways

  • Senotherapeutics target cellular senescence, offering new antiaging dermatology strategies to improve skin health.
  • Telehealth complexities require physician assistants to adapt to evolving practice environments.
SHOW MORE

Catch up on dermatology news, highlights, and insights from the past 24 hours.

Daily Derm Times logo

To stay up-to-date with the latest dermatology news, sign up to receive our eNewsletters.

New Concepts in Antiaging Dermatology

New antiaging dermatology concepts target cellular senescence to slow aging and improve skin health with senotherapeutics.

Navigating Challenges to Prepare for the Future of Telehealth

Michael Rubio, PA-C, and Renata Block, MMS, PA-C discuss the complexities associated with practicing telemedicine, especially as a PA.

Rezpeg vs Existing Therapies: A Paradigm Shift in Atopic Dermatitis Treatment

Jonathan Zalevsky, PhD, discusses the fundamentally different path of Rezpeg compared with existing IL-4 and IL-13 inhibitors in atopic dermatitis.

Cross-Cultural Perspectives on Facial Aging

Recent research underscores the critical role of periorbital skin care in maintaining a youthful and healthy appearance across all ethnicities.

Jacqueline Watchmaker MD, FAAD, Discusses the Innovative InterFuse Treatment Cream for Aging Skin

“I think some key things that stand out to me are that it's safe, effective, backed by rigorous clinical data, and has very high patient satisfaction,” Watchmaker said about the new product.

AI Model Shows Promise in Reducing Skin Cancer Detection Bias

A novel AI model was able to achieve 99.86% accuracy for diagnosing skin conditions, even in people with darker skin tones or excessive hair.

Patrick Burnett, MD, PhD, Highlights Arcutis’ New Seborrheic Dermatitis Initiative With Odell Beckham Jr.

The overwhelmingly positive feedback from both clinicians and patients reinforces the unmet need roflumilast foam is addressing in seborrheic dermatitis care.

Related Videos
infectious disease
© 2025 MJH Life Sciences

All rights reserved.